Doctor profile · Federal record

Dr. Sarah Shriner

Physician Assistant · Student in an Organized Health Care Education/Training Program · Wichita, KS

  • NPI 1710539879
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 7 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3121 N Webb RD Ste 101
Wichita, KS 672268119
(316) 261-3130
fax (316) 261-3275
Mailing address
1637 N Woodland Ave
Wichita, KS 672032739

Credentials & registration

NPPES · NUCC
NPI registered
July 2019 — 7 yrs on file
Profile last updated
May 5, 2022
Year of graduation
2019 — 7 yrs since
Specialty taxonomy
363A00000X — NUCC code
State license (1)
Kansas #15-02300

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1710539879. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
8,477
Distinct HCPCS
10
Medicare allowed
$251,755
HCPCS Description Services Patients Avg allowed
J3380 Injection, vedolizumab, 1 mg 6,601 16 $22
J1745 Injection, infliximab, excludes biosimilar, 10 mg 1,140 13 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 381 286 $100
99213 Established patient office or other outpatient visit, 20-29 minutes 126 117 $70
99204 New patient office or other outpatient visit, 45-59 minutes 71 71 $131
99215 Established patient office or other outpatient visit, 40-54 minutes 52 47 $142
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes 37 29 $39
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 35 22 $49
96413 Administration of chemotherapy into vein, 1 hour or less 17 13 $100
96415 Administration of chemotherapy into vein, each additional hour 17 13 $22

In context: peer comparison

Among 95 peers in this city , average services per provider: 189. This provider delivers 45× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,424
Transactions
84
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 23 $305.63
Takeda Pharmaceuticals U.S.A., Inc. 14 $225.24
Janssen Biotech, Inc. 17 $198.35
Lilly USA, LLC 7 $186.32
Intercept Pharmaceuticals, Inc. 4 $56.20
Celltrion USA Inc. 3 $48.92
Ardelyx, Inc. 2 $35.91
Ipsen Biopharmaceuticals, Inc 2 $33.07
Sandoz Inc. 2 $30.36
Merck Sharp & Dohme LLC 2 $28.67
Celgene Corporation 2 $28.63
Regeneron Healthcare Solutions, Inc. 2 $28.39
Gilead Sciences, Inc. 2 $28.08
Salix Pharmaceuticals, a division of Bausch Health US, LLC 1 $24.92
QOL Medical, LLC 1 $24.77

By nature of payment

Food and Beverage
$1,406
Education
$18

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,128
Patients
269
Total drug cost
$206,695
Drug Type Claims Patients Total cost
Pantoprazole Sodium Generic 393 106 $4,587
Dicyclomine Hcl Generic 86 37 $1,352
Omeprazole Generic 85 29 $1,230
Colestipol Hcl Generic 84 34 $10,294
Famotidine Generic 75 22 $826
Linzess (Linaclotide) Brand 63 0 $41,635
Sucralfate Generic 49 16 $3,494
Spironolactone Generic 47 12 $1,415
Mirtazapine Generic 42 0 $403
Colesevelam Hcl Generic 38 0 $6,441

Frequently asked questions

Auto-generated from federal data
What is Dr. Sarah Shriner's medical specialty?
Dr. Sarah Shriner practices Physician Assistant in Wichita, KS.
Where does Dr. Sarah Shriner practice?
Dr. Sarah Shriner practices at 3121 N Webb RD Ste 101, Wichita, KS 672268119. Office phone: 3162613130.
What is Dr. Sarah Shriner's NPI?
Dr. Sarah Shriner's National Provider Identifier (NPI) is 1710539879, issued by NPPES.
Does Dr. Sarah Shriner accept Medicare assignment?
Yes. Dr. Sarah Shriner accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sarah Shriner commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.